ProCE Banner Activity

Sequencing Treatment in HER2-Positive Metastatic Breast Cancer

Slideset

Downloadable slides on optimal sequencing strategies for patients with HER2-positive metastatic breast cancer.

Released: March 13, 2024

Expiration: March 12, 2025

Share

Faculty

Kevin Kalinsky

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

Ruta D Rao

Ruta D Rao, MD

Professor of Medicine
Medical Director, Rush University Cancer Center
Rush University Medical Center
Chicago, Illinois

Sara M. Tolaney

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Associate Director, Susan F. Smith Center for Women’s Cancers
Senior Physician, Dana-Farber Cancer Institute
Associate Professor of Medicine, Harvard Medical School
Boston, Massachusetts

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.